Status:
COMPLETED
Chronic Obstructive Pulmonary Disease (COPD) and Advance Directives
Lead Sponsor:
Hôpital NOVO
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to evaluate if the participation of COPD patients to a workshop on advance directives increases the number of patients who write them.
Detailed Description
Chronic Obstructive Disease is a common disease and should be the third leading cause of death in 2020. Patient hospitalized for an exacerbation of their COPD have a median survival of 2 years and 50%...
Eligibility Criteria
Inclusion
- COPD Gold 3 or 4 and Curtis criteria
Exclusion
- left to the discretion of the investigator if he finds that it will not be beneficial for the patient : for example if the workshop is judged to be at risk of being anxiety-provoking
Key Trial Info
Start Date :
May 16 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2020
Estimated Enrollment :
525 Patients enrolled
Trial Details
Trial ID
NCT04459143
Start Date
May 16 2019
End Date
October 31 2020
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Les Cèdres SSR Pneumologie / Réhabilitation Respiratoire
Aincourt, France, 95510